Document Detail


Antifibrillatory effect of esmolol alone and in combination with lidocaine.
MedLine Citation:
PMID:  8907799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The primary objective of this study was to determine the effect of esmolol, administered alone and in combination with lidocaine, on ventricular fibrillation threshold (VFT) in pigs. A secondary objective was to determine the relationship between blood esmolol concentrations and VFT. We determined VFT using a train of electrical stimuli delivered to the right ventricle after eight paced beats at a basic cycle length of 285 ms. Current was increased in 2-mA increments until VF occurred. VFT determinations were performed during administration of esmolol 1,000 mu g/kg/min, during a continuous infusion of lidocaine, and during infusion of esmolol and lidocaine in combination. Mean increases in VFT from baseline during infusion of esmolol and lidocaine alone were 32.3 +/- 12.9 and 8.5 +/- 7.2 mA, respectively (p < 0.05, each drug compared with baseline; p < 0.05, esmolol vs. lidocaine). Mean increase in VFT from baseline during infusion of the combination was 52.0 +/- 22.0 mA (p < 0.05 as compared with baseline and with esmolol or lidocaine alone). The relationship between blood esmolol concentrations and VFT was described by a counterclockwise hysteresis curve, suggesting delay in equilibration of esmolol between blood and site of effect. The antifibrillatory efficacy of esmolol is significantly greater than that of lidocaine in this model. Administration of the two agents in combination resulted in significantly greater antifibrillatory efficacy than that associated with either drug administered alone.
Authors:
J E Tisdale; H Sun; H Zhao; C D Fan; R D Colucci; J Kluger; M S Chow
Related Documents :
12382109 - Effects of anesthesia on efferent-mediated adaptation of the dpoae.
8721389 - Dibutyryl camp improves systemic vasoconstriction caused by endotoxin in dogs.
24255119 - Physical activity is medicine for older adults.
23289529 - T'ai chi as exercise among middle-aged and elderly chinese in urban china.
24140059 - Ginsenoside rg3 improves cardiac mitochondrial population quality:mimetic exercise trai...
7426229 - Effect of low concentrations of halothane on the oxygen electrode.
17446809 - Physical activity levels in adults with congenital heart disease.
21717119 - Exercise intensity and oxygen uptake kinetics in african-american and caucasian women.
17032489 - Predicting self-efficacy using illness perception components: a patient survey.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  27     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1997-03-13     Completed Date:  1997-03-13     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  376-82     Citation Subset:  IM    
Affiliation:
Hartford Hospital, University of Connecticut, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Animals
Anti-Arrhythmia Agents / administration & dosage*
Blood Pressure / drug effects
Drug Therapy, Combination
Heart Rate / drug effects
Lidocaine / administration & dosage*
Propanolamines / blood,  pharmacology,  therapeutic use*
Swine
Ventricular Fibrillation / drug therapy*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Propanolamines; 137-58-6/Lidocaine; 84057-94-3/esmolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
Next Document:  Simvastatin releases Ca2+ from a thapsigargin-sensitive pool and inhibits InsP3-dependent Ca2+ mobil...